FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and concerns a combined composition for treating multiple sclerosis (MS) and chronic inflammatory demyelinating polyneuropathy (CIDP) comprising (i) an antibody, a fragment or derivative directed against the HERV-W envelope protein (HERV-W Env), and (ii) a retroviral reverse transcriptase inhibiting agent. Group of inventions also relates to the use of an antibody, fragment or derivative directed against the HERV-W envelope protein (HERV-W Env), in combination with a retroviral reverse transcriptase inhibiting drug for treating multiple sclerosis (MS) and chronic inflammatory demyelinating polyneuropathy (CIDP).
EFFECT: group of inventions provides creating an effective antiretroviral drug aimed at HERV-W.
7 cl, 3 ex, 7 dwg, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| BISPECIFIC MOLECULES, IMMUNOREACTIVE WITH IMMUNE EFFECTOR CELLS EXPRESSING AN ACTIVATING RECEPTOR | 2014 |
|
RU2721707C2 |
| HUMAN ANTIBODIES BINDING TO ROR2 | 2018 |
|
RU2784586C2 |
| IMMUNOGENS FOR VACCINATION AGAINST HIV | 2013 |
|
RU2721274C2 |
| CHIMERIC ANTIGENIC RECEPTORS TO BCMA | 2015 |
|
RU2747457C2 |
| IL-12 COMPOSITIONS AIMED AT EDB | 2019 |
|
RU2758143C1 |
| USE OF IL-18-BINDING PROTEIN (IL-18BP) IN INFLAMMATORY DISEASES | 2014 |
|
RU2731713C2 |
| ANTIBODY TO PD-L1, ITS ANTIGEN-BINDING FRAGMENT, AND THEIR PHARMACEUTICAL USE | 2019 |
|
RU2778085C2 |
| ELEMENTS THAT BIND TO IL-1 BETA | 2013 |
|
RU2711118C2 |
| MONOCLONAL ANTIBODY AGAINST MELK AND ITS USE | 2017 |
|
RU2756982C2 |
| COMBINATION THERAPY OF ANTIBODY TO PROGASTRIN AND IMMUNOTHERAPY FOR CANCER TREATMENT | 2018 |
|
RU2784604C2 |
